Relistor is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Salix Pharmaceuticals, Inc.. The primary component is Methylnaltrexone Bromide.
Product ID | 65649-552_1357dc78-e4c6-4f46-818b-b3bf1f02ef97 |
NDC | 65649-552 |
Product Type | Human Prescription Drug |
Proprietary Name | Relistor |
Generic Name | Methylnaltrexone Bromide |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2008-04-24 |
Marketing Category | NDA / NDA |
Application Number | NDA021964 |
Labeler Name | Salix Pharmaceuticals, Inc. |
Substance Name | METHYLNALTREXONE BROMIDE |
Active Ingredient Strength | 8 mg/.4mL |
Pharm Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA],Quaternary Ammonium Compounds [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2008-04-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021964 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-04-24 |
Ingredient | Strength |
---|---|
METHYLNALTREXONE BROMIDE | 8 mg/.4mL |
SPL SET ID: | c488fb7c-0a5b-487c-b452-996809d1cb99 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
65649-150 | Relistor | Methylnaltrexone bromide |
65649-551 | Relistor | Methylnaltrexone bromide |
65649-552 | Relistor | Methylnaltrexone bromide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RELISTOR 78939607 3535582 Live/Registered |
SALIX PHARMACEUTICALS, INC. 2006-07-28 |
RELISTOR 77324836 3592407 Dead/Cancelled |
SALIX PHARMACEUTICALS, INC. 2007-11-08 |